Mosaic ImmunoEngineering (CPMV) Tax Provisions (2010 - 2025)

Mosaic ImmunoEngineering (CPMV) posted quarterly Tax Provisions of $2400.0 for Q2 2025, little changed quarter-over-quarter from $2400.0 in Q4 2024.

Mosaic ImmunoEngineering (CPMV) Tax Provisions (2010 - 2025) Analysis & Trends

Mosaic ImmunoEngineering's Tax Provisions history runs 16 years deep, the most recent figure standing at $2400.0 for Q2 2025.

In Q2 2025, Tax Provisions changed N/A year-over-year to $2400.0; the TTM figure through Mar 2026 stood at $2400.0 (changed 0.0% YoY), while the FY2025 annual figure was $2400.0, changed 0.0% from the prior year.
Tax Provisions for Q2 2025 stood at $2400.0, roughly flat from $2400.0 in the prior quarter.
The five-year high for Tax Provisions was $2400.0 in Q1 2021, with the low at $2400.0 in Q1 2021.
The 5-year median for Tax Provisions is $2400.0 (2021), against an average of $2400.0.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	59.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	13.31 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	1.90 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-90.33 Mn
10	Mosaic ImmunoEngineering	527,536.97	527,536.97	-	-

Download Data